Capital International Investors Guardant Health, Inc. Transaction History

Capital International Investors

$590 Billion
Q3 2025

A detailed history of Capital International Investors transactions in Guardant Health, Inc. stock. As of the latest transaction made, Capital International Investors holds 4,689,241 shares of GH stock, worth $443 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

4,689,241

Previous 4,976,458 5.77%

Holding current value

$443 Million

Previous $259 Million 13.13%

% of portfolio

0.05%

Previous 0.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$40.98 - $67.42 $11.8 Million - $19.4 Million	-287,217 Reduced 5.77%	4,689,241 $293 Million
Q2 2025 Aug 13, 2025	SELL	$37.05 - $52.04 $6.35 Million - $8.91 Million	-171,266 Reduced 3.33%	4,976,458 $259 Million
Q1 2025 May 12, 2025	BUY	$31.77 - $49.94 $21.4 Million - $33.7 Million	674,482 Added 15.08%	5,147,724 $219 Million
Q3 2024 Nov 13, 2024	BUY	$22.3 - $36.29 $100,773 - $163,994	4,519 Added 0.1%	4,473,242 $103 Million
Q2 2024 Aug 13, 2024	BUY	$16.07 - $31.84 $10.4 Million - $20.6 Million	645,784 Added 16.89%	4,468,723 $129 Million

Q1 2024 May 14, 2024	SELL	$17.13 - $26.91 $3.06 Million - $4.81 Million	-178,864 Reduced 4.47%	3,822,939 $78.9 Million
Q4 2023 Feb 13, 2024	BUY	$21.58 - $29.5 $23.2 Million - $31.7 Million	1,074,452 Added 36.7%	4,001,803 $108 Million
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $833,520 - $1.29 Million	32,307 Added 1.12%	2,927,351 $86.8 Million
Q2 2023 Aug 11, 2023	SELL	$20.94 - $38.01 $90.7 Million - $165 Million	-4,329,827 Reduced 59.93%	2,895,044 $104 Million
Q1 2023 May 15, 2023	SELL	$22.92 - $33.76 $14.4 Million - $21.2 Million	-627,036 Reduced 7.99%	7,224,871 $169 Million
Q4 2022 Feb 14, 2023	BUY	$25.44 - $59.78 $43.2 Million - $102 Million	1,697,998 Added 27.59%	7,851,907 $214 Million
Q3 2022 Nov 14, 2022	BUY	$43.66 - $61.0 $25.2 Million - $35.1 Million	576,044 Added 10.33%	6,153,909 $331 Million
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $14.3 Million - $38.4 Million	496,241 Added 9.77%	5,577,865 $225 Million
Q1 2022 May 16, 2022	BUY	$48.25 - $100.49 $102 Million - $212 Million	2,110,240 Added 71.02%	5,081,624 $337 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $72.6 Million - $98.5 Million	818,309 Added 38.01%	2,971,384 $297 Million
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $15.7 Million - $21.1 Million	159,413 Added 8.0%	2,153,075 $269 Million
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $23.4 Million - $35.3 Million	213,308 Added 11.98%	1,993,662 $248 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $36.2 Million - $51 Million	284,652 Added 19.03%	1,780,354 $272 Million
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $150 Million - $203 Million	1,495,702 New	1,495,702 $193 Million

Others Institutions Holding GH

# of Institutions

450

Shares Held

125M

Call Options Held

2.18M

Put Options Held

2.69M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $9.65B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Investors with notifications on news.

Account

Capital International Investors Guardant Health, Inc. Transaction History